Ten-year experience on retransurethral resection of nonmuscle-invasive bladder cancer. Are we doing on the right patients?

被引：0
|
作者：
Wong, K. W. [1 ]
Lai, T. C. T. [1 ]
Tsang, C. F. [1 ]
Ho, B. [1 ]
Ng, A. T. L. [1 ]
Ma, W. K. [1 ]
Tsu, J. H. L. [1 ]
Yiu, M. K. [1 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Div Urol, Dept Surg, Hong Kong, Hong Kong, Peoples R China
来源：
BJU INTERNATIONAL | 2017年 / 119卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [31] Re: Transurethral En Bloc Submucosal Hydrodissection vs Conventional Resection for Resection of Nonmuscle-Invasive Bladder Cancer (HYBRIDBLUE): A Randomised, Multicentre Trial
    不详
    JOURNAL OF UROLOGY, 2021, 206 (05): : 1326 - 1327
  • [32] Safety and efficacy of en bloc transurethral resection versus conventional transurethral resection for primary nonmuscle-invasive bladder cancer: a meta-analysis
    Zhang, Dong
    Yao, Lifeng
    Yu, Sui
    Cheng, Yue
    Jiang, Junhui
    Ma, Qi
    Yan, Zejun
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [33] Safety and efficacy of en bloc transurethral resection versus conventional transurethral resection for primary nonmuscle-invasive bladder cancer: a meta-analysis
    Dong Zhang
    Lifeng Yao
    Sui Yu
    Yue Cheng
    Junhui Jiang
    Qi Ma
    Zejun Yan
    World Journal of Surgical Oncology, 18
  • [34] Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional Experience
    Khanna, Abhinav
    Miest, Tanner
    Sharma, Vidit
    Campbell, Rebecca
    Hensley, Patrick
    Thapa, Prabin
    Zganjar, Andrew
    Tollefson, Matthew K.
    Thompson, R. Houston
    Frank, Igor
    Karnes, R. J.
    Murthy, Prithvi B.
    Haber, Georges P.
    Navai, Neema
    Kamat, Ashish M.
    Dinney, Colin
    Lee, Byron
    Boorjian, Stephen A.
    JOURNAL OF UROLOGY, 2022, 207 (03): : 551 - 558
  • [35] Defining innate immune training potential as a predictor of Bacillus Calmette-Guerin immunotherapy response in nonmuscle-invasive bladder cancer.
    Jiang, Song
    Redelman-Sidi, Gil
    Pietzak, Eugene J.
    Bochner, Bernard H.
    Glickman, Michael S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [36] BLADDER-PRESERVING 'TRIMODALITY' THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER: TEN-YEAR RETROSPECTIVE MONO-INSTITUTIONAL EXPERIENCE
    Miranda, Giulia
    Mazzeo, Ercole
    Sabbatini, Roberto
    Mucciarini, Claudia
    Lauro, Chiara
    Vernaleone, Marco
    Nicolini, Massimiliano
    Lohr, Frank
    Bruni, Alessio
    ANTICANCER RESEARCH, 2023, 43 (10) : 4776 - 4777
  • [37] Uromonitor: Clinical Validation and Performance Assessment of a Urinary Biomarker Within the Surveillance of Patients With Nonmuscle-Invasive Bladder Cancer
    Ramos, Pedro
    Bras, Joao P.
    Dias, Carolina
    Bessa-Goncalves, Mafalda
    Botelho, Francisco
    Silva, Joao
    Silva, Carlos
    Pacheco-Figueiredo, Luis
    JOURNAL OF UROLOGY, 2025, 213 (03): : 304 - 312
  • [38] Predicting Recurrence and Progression in Chinese Patients With Nonmuscle-invasive Bladder Cancer Using EORTC and CUETO Scoring Models
    Xu, Tianyuan
    Zhu, Zhaowei
    Zhang, Xiaohua
    Wang, Xianjin
    Zhong, Shan
    Zhang, Minguang
    Shen, Zhoujun
    UROLOGY, 2013, 82 (02) : 387 - 393
  • [39] Combined Chemohyperthermia: 10-Year Single Center Experience in 160 Patients with Nonmuscle Invasive Bladder Cancer
    Arends, Tom J. H.
    van der Heijden, Antoine G.
    Witjes, J. Alfred
    JOURNAL OF UROLOGY, 2014, 192 (03): : 708 - 713
  • [40] Predicting recurrence of nonmuscle-invasive bladder cancer (Ta-T1) A study based on 477 patients
    Lu, Mengxin
    Chen, Song
    Zhou, Qiang
    Wang, Lu
    Peng, Tianchen
    Wang, Gang
    MEDICINE, 2019, 98 (28)
12345